Product image of Xembify (Human Normal Immunoglobulin) supplied by GNH India

Xembify

Active Ingredient:
Human Normal Immunoglobulin
Origin:
EU

Xembify (Human Normal Immunoglobulin)

Xembify is a human normal immunoglobulin solution for subcutaneous use, providing passive immunity support. This therapy is used to treat primary immunodeficiency disorders. It is administered under medical supervision. Xembify is manufactured by Instituto Grifols, S.A. in the EU.

Manufacturer / TM Owner

Instituto Grifols, S.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Xembify is used to treat primary immunodeficiency disorders by providing antibodies that the body lacks. It may also be used for other conditions as prescribed by a healthcare provider. This therapy helps support the immune system in individuals with weakened defenses. Xembify is administered via subcutaneous injection.

Side Effects

  • Xembify works by supplying antibodies to help the immune system fight infections. Users may experience improved resistance to common illnesses over time. The effects vary by individual and depend on the prescribed treatment plan. Regular use is typically required to maintain benefits.

Precautions & Warnings

  • Xembify should be stored properly to maintain its effectiveness. Always follow the handling and administration instructions provided by a healthcare professional. Report any unusual reactions or side effects to your doctor immediately. Keep out of reach of children and pets.

Avoid Interactions

  • Xembify may interact with live vaccines, potentially reducing their effectiveness. Inform your healthcare provider about all medications and supplements you are taking. Avoid mixing Xembify with other intravenous solutions unless directed by a doctor. Alcohol and certain foods may not directly interact but should be consumed cautiously.

Frequently Asked Questions

Xembify is used to treat primary immunodeficiency disorders by providing antibodies that the body lacks.

Xembify is administered via subcutaneous injection, typically under medical supervision.

Some users may experience mild reactions at the injection site or general discomfort. Serious side effects are rare but should be reported to a doctor.

The safety of Xembify during pregnancy has not been established. Consult your healthcare provider for personalized advice.

Xembify is manufactured by Instituto Grifols, S.A. in the European Union.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Human Normal Immunoglobulin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT